WednesdayFeb 03, 2021 2:02 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Set to Revolutionize Bladder Cancer Visualization

The established and most prominent method of visualizing bladder cancer, white light, lacks the clarity needed to detect finer margins of tumors, which increases the likelihood of recurrence The more recent, improved method, blue light, provides clarity yet introduces cost barriers to adoption Imagin Medical’s i/Blue Imaging(TM) System combines the best of both methods, clarity and real-time visualization at a lower cost The system is highly adaptable to current endoscopic instruments, making it easy and affordable to implement For over 30 years, the standard of visualizing bladder cancer during surgery has been white light illumination through an endoscopic procedure called…

Continue Reading

TuesdayFeb 02, 2021 3:08 pm

Brain Scientific Inc. (BRSF) E-Tattoo Will Offer AI Solutions for Neurology

BRSF paving way with next wave of innovation for neurology: e-tattoos Acceptance of telemedicine, AI here to stay following pandemic Scientists have learned how to read brain waves using minimally invasive, implantable, four-channel micro EEG to better monitor continuous seizures The COVID-19 pandemic has accelerated several changes to American culture, many of which appear to be here to stay. According to Harvard experts, some of those changes include movement towards a cashless society, increased remote work, the decline of brick-and-mortar retail, and a new approach to health that includes an acceptance of telemedicine and artificial intelligence (“AI”) (https://ibn.fm/f9IJ5). Brain Scientific…

Continue Reading

TuesdayFeb 02, 2021 3:00 pm

Study Shows Patients Want Mental Health Care to Remain Online Post-Coronavirus

After a few failed attempts at getting patients who would agree to see a telehealth psychiatrist, Jennifer Severe, a psychiatrist who had helped introduce telehealth initiatives at the University of Michigan outpatient clinic, and her colleagues were flooded with numerous videos chats after the pandemic hit. Non-urgent healthcare in Michigan was forced to go digital, with phone calls and video chats becoming the primary means for patients to communicate with their psychologists and psychiatrists. Nine months later, this is how a majority of patients have operated. Now, a new study led by Severe proposes that more than half of these…

Continue Reading

MondayFeb 01, 2021 3:00 pm

Half of All Covid-19 Medical Workers at Risk of Mental Health Issues, New Research Shows

A recent study conducted by researchers from the University of Utah suggests that more than half of the emergency responders involved in coronavirus care are at risk of developing one or more mental health conditions, including insomnia, alcohol abuse, anxiety, depression and acute traumatic stress. The scientists discovered that the risk of these mental health problems was similar to rates that had been observed during natural disasters such as Hurricane Katrina and 9/11. The corresponding author of the study, Andrew J. Smith, explained that while a majority of emergency responders and health-care professionals weren’t necessarily going to develop post-traumatic stress…

Continue Reading

FridayJan 29, 2021 3:15 pm

Study Discovers Link Between Pandemic Fears, PTSD

Researchers from Flinders University conducted an online study that explored different individuals’ responses to the coronavirus pandemic. The study involved 1,040 participants from five Western nations. The researchers discovered that 13.2% of the sample from these countries had symptoms associated with PTSD that qualified for a clinical diagnosis. This in spite of the fact that only 5% of the total number of participants reported that close friends and family had tested positive for the coronavirus and only 2% disclosed that they had tested positive themselves. The survey, which was conducted online, analyzed a range of responses to common symptoms of…

Continue Reading

FridayJan 29, 2021 12:13 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

Torrey Hills Capital is a leading investor and financial public relations firm that offers extensive expertise in investor relations, corporate communications and other market support operations The services provided to Imagin Medical will be overseen by Torrey Hills Founder and Principal Cliff Mastricola Imagin believes its proprietary imaging technology, the i/Blue Imaging System(TM), will establish a new standard of care in visualizing cancer during minimally invasive procedures Company’s current focus is bladder cancer, the 6th most prevalent form of cancer and most expensive to treat Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has engaged the services of…

Continue Reading

ThursdayJan 28, 2021 3:52 pm

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Flaws in the U.S. health-care system revealed during COVID-19 pandemic Lack of medication adherence can lead to serious issues, including worsening of disease, possible death and increased costs United Medical offers solutions for poor patient-physician communication and inadequate medication knowledge The COVID-19 pandemic has revealed flaws in the U.S. health-care system, including flaws that require patients and caregivers to take a more active and educated role. United Medical Equipment Business Solutions Network (“UME”) provides reliable resources and solutions to help providers work more proficiently, health-care systems work smarter, and patients live healthier lives. “This pandemic is a watershed moment in…

Continue Reading

ThursdayJan 28, 2021 2:30 pm

Study Links Coronavirus to Life-Threatening Blood Clots Found in Lower Limbs

According to study results reported in “Radiology", researchers have discovered that the coronavirus is linked to fatal blood clots in leg arteries. The researchers stated that coronavirus patients who were in short supply of blood to their lower limbs tended to have bigger clots, and remarkably higher amputation rates and death, especially in comparison with COVID-negative individuals who had identical conditions. When the pandemic was at its peak in New York, radiologists from a medical center in the Bronx noted a rise in the number of patients who tested positive for lower extremity arterial thrombosis on CT angiography exams. The…

Continue Reading

ThursdayJan 28, 2021 2:16 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost 14,000 women will die from the disease (https://ibn.fm/4yfJn). Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women; ovarian cancer causes more deaths than any other cancer of the female reproductive…

Continue Reading

WednesdayJan 27, 2021 3:46 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000